Literature DB >> 12803244

A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies.

Taisuke Iwaoka1.   

Abstract

A subtype of idiopathic type 1 diabetes with a rapid onset and no diabetes-related antibodies has been recently advocated as non-autoimmune fulminant type 1 diabetes. However, it is not definite yet that this subtype is always caused by non-autoimmune mechanism. A 48-year-old man was admitted to our hospital because of high plasma glucose and renal insufficiency. Laboratory findings were as follows: plasma glucose 1052 mg/dL, urinary ketone bodies (+/-), arterial blood pH 7.44, bicarbonate 23.8 mmol/L, base excess 0.3 mmol/L, plasma osmolality 342 mOsm/L, serum creatinine 2.1 mg/dL, blood urea nitrogen 69.7 mg/dL, and serum creatine kinase 1024 IU/L, giving a diagnosis of acute renal failure secondary to rhabdomyolysis associated with diabetes. Urinary C-peptide reactivity was 4.7 microg/day. The level of HbAlc was 7.0%, not so high as compared to that of plasma glucose, indicating an aggravation of diabetes within the recent short period. Antibodies to islet cell antigen, IA-2 and insulin were negative, while those to glutamic acid decarboxylase (GAD) were positive at 13.1 U/mL, which were negative half a year and two years and a half later. Serum amylase level was within normal range at admission, increased to 380 IU/L and normalized in 4 to 5 weeks as serum creatinine lowered. These data are compatible to the diagnosis of fulminant type 1 diabetes. However, the present case is different from others in positive antibodies to GAD at admission that turned to be negative subsequently. Considering our results and others together, further investigations are necessary to clarify whether all cases of fulminant type 1 diabetes are non-autoimmune or some of them are caused by autoimmune mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12803244     DOI: 10.1507/endocrj.50.225

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

1.  Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetes.

Authors:  Hidekatsu Yanai; Sumie Moriyama
Journal:  World J Diabetes       Date:  2011-05-15

2.  Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes.

Authors:  Akinori Kanzaki; Morihiro Matsuda; Shinji Yokota; Kenji Takai; Jun Murai; Akihito Otsuka; Hidenori Koyama; Tadashi Nakamura
Journal:  Diabetol Int       Date:  2021-08-26

3.  Fulminant Type 1 Diabetes in Children: A Multicenter Study in China.

Authors:  Yi Gu; Yi Wang; Pin Li; Haiyan Wei; Linqi Chen; Qianqi Liu; Yu Liu; Qiaozhi Yang; Xinran Cheng; Lanjie He; Liya Wei; Zhiying Zhu; Yongxing Chen; Fengyun Wang; Xing Shi; Yuxian Cheng; Yan Wei; Jianing Yu; Chunxiu Gong
Journal:  J Diabetes Res       Date:  2017-09-26       Impact factor: 4.011

4.  The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study.

Authors:  N Izawa; H Shiokawa; R Onuki; K Hamaji; K Morikawa; H Saji; H Ohashi; S Kasugai; N Hayakawa; T Ohara; Y Sunakawa
Journal:  ESMO Open       Date:  2022-03-02

5.  Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus.

Authors:  Megu Yamaguchi Baden; Akihisa Imagawa; Hiromi Iwahashi; Iichiro Shimomura; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Hiroshi Kajio; Eiji Kawasaki; Yumiko Kawabata; Akira Shimada; Kazuma Takahashi; Shoichiro Tanaka; Kazuki Yasuda; Hisafumi Yasuda; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  Diabetol Int       Date:  2015-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.